Hamborner REIT AG (HABA)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 4.140 |
|---|---|
| 52-week range | 3.960 – 5.350 |
| Return, 1 month / 3 months | −2.5% / −6.0% |
| Return, 1 year / 3 years | −14.7% / −15.9% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 21.2% |
| Worst drawdown (1 year) | -19.6% |
| Average daily value traded | 0.33M EUR |
| Dividend yield | 9.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hamborner REIT AG is a German real estate company that owns and manages a portfolio of commercial properties, chiefly office buildings and retail premises, located in cities across Germany. It leases these properties to business tenants and derives income from rental agreements. The company is based in Duisburg and operates as a real estate investment trust, holding its properties for the long term rather than trading them.
The shares are listed on the XETRA Stock Exchange in Germany under the code HABA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hamborner REIT AG (HABA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 4.140 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 276 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.7% and over the last three months it fell 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.0% | ||
| From 52-week high | -22.0% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.0% | ||
| 6-month return | -5.9% | ||
| 12-month return, skipping the last month | -12.5% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.6% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.33M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 9.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | −2.5% |
| 3 months | −6.0% |
| 6 months | −5.9% |
| 1 year | −14.7% |
| 3 years | −15.9% |
| 5 years | −39.8% |
Signals
| 50-day / 200-day average | 4.189 / 4.358 |
|---|---|
| Golden / death cross (60 days) | Death, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.076 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.3900 |
| 27 Jun 2025 | EUR 0.4800 |
| 26 Apr 2024 | EUR 0.4800 |
| 28 Apr 2023 | EUR 0.4700 |
| 29 Apr 2022 | EUR 0.4700 |
| 30 Apr 2021 | EUR 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.